CLINICAL_TRIALS
trial_result
· 2013-09-02
Clinical Trial Update: Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL) [Phase 2]
Summary
Phase 2 trial data evaluate the safety and efficacy of lenalidomide in patients with relapsed or refractory aggressive non-Hodgkin lymphoma. Results were posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene Corporation | Conditions: Non-Hodgkins Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-09-02